Key result
The provided text contains web shop instructions and lacks any clinical data regarding the correlation between serum adiponectin and risk factors in coronary artery disease.
Why the study?
Are serum adiponectin levels correlated with hsCRP and cardiovascular risk factors in patients with coronary artery disease?
Are serum adiponectin levels correlated with hsCRP and cardiovascular risk factors in patients with coronary artery disease?
Lower serum adiponectin levels are associated with acute coronary syndromes and negatively correlate with hsCRP, suggesting a potential predictive value for the development of ACS.
No relevant clinical data found; leaves adiponectin–hsCRP correlation in CAD open for investigation.
BACKGROUND: To investigate the correlation between serum adiponectin (ADP) and high sensitivity C-reactive protein (hsCRP) as well as risk factors in patients with coronary artery disease (CAD). METHODS: 90 patients with coronary artery disease (CAD) who were subjected to coronary angiography were involved. Among the patients, 41 had acute myocardial infarction (AMI), 27 had unstable angina pectoris (UAP), and 22 had stable angina pectoris (SAP). 20 healthy people comprised the control group (NC). Serum ADP was measured using an enzyme linked immunosorbent assay (ELISA). hsCRP was measured using immunoturbidimetry. Cardiovascular risk factors were also investigated. RESULTS: The serum ADP concentrations in the AMI group and the UAP group were significantly lower than those in the SAP group (p < 0.05) and the NC group (p < 0.01). The hsCRP concentrations in the AMI group and the UAP group were significantly higher than those in the SAP group (p < 0.05) and the NC group (p < 0.05). The ADP concentration was negatively correlated with the hsCRP concentration in the acute coronary syndrome group (r = -0.33, p < 0.05). Moreover, the more risk factors there were, the lower the serum ADP concentration in the CAD patients was. CONCLUSIONS: Serum ADP is associated with CAD and cardiovascular risk factors. ADP has anti-inflammatory and anti-atherogenic properties, which may have a predictive value for the genesis and development of ACS.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2013) studied Coronary Artery Disease. Serum Adiponectin was evaluated. The provided text contains web shop instructions and lacks any clinical data regarding the correlation between serum adiponectin and risk factors in coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: